Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 4, 1997, Pages 367-370

  Giverhaug, Trude ^a   Fuskevaag, Ole Martin ^a   Aarbakke, Jarle ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

6 Thioguanine nucleotide; Interaction; Metabolism; Methylmercaptopurine

Indexed keywords

DRUG METABOLITE; MERCAPTOPURINE; METHOTREXATE; THIOPURINE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HEMOLYSATE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

6-MERCAPTOPURINE; ANIMALS; ERYTHROCYTES; GUANINE NUCLEOTIDES; MALE; METHOTREXATE; METHYLTHIOINOSINE; METHYLTRANSFERASES; NUCLEIC ACID SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; THIONUCLEOTIDES;

EID: 0030952175     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050672     Document Type: Article

References (21)

1. Balis FM, Holcenberg JS, Zimm S, Tubergen D, Collins JM, Murphy RF, Gilchrist GS, Hummond D, Poplack DG (1987) The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther 41: 384
2. Bennett LL, Allan PW (1971) Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine. Cancer Res 31: 152
3. Bökkerink JPM, de Abreu RA, van Laarhoven JPRM, Bakker MAH, Hulscher TW, Schretlen EDAM, de Bruijn CHMM (1986) Increased availability of phosphoribosyl pyrophosphate as the basis for enhanced 6-mercaptopurine incorporation by methotrexate, in cultured human lymphoblasts Adv Exp Med Biol 195: 135
4. Bökkerink JPM, Bakker MAH, Hulscher TW, de Abreu RRA, Schretlen EDAM, van Laarhoven JPRM, de Bruyn CHMM (1986) Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Biochem Pharmacol 35: 3549
5. Bökkerink JPM, Stet EH, de Abreu RA, Damen FJM, Hulscher TW, Bakker MAH, van Baal JA (1993) 6-mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol 45: 1455
6. Giverhaug T, Fuskevaag O-M, Aarbakke J (1996) Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: Comparison of two methods (in press)
7. Innocenti F, Danesi R, Di Paolo A, Loru B, Favre C, Nardi M, Bocci G, Nardini D, Macchia P, Del Tacca M (1996) Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate. Cancer Chemother Pharmacol 37: 409
8. Klemetsdal B, Straume B, Lysaa R, Giverhaug T, Aarbakke J (1995) Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity. Eur J Clin Pharmacol 48: 495
9. Lennard L (1987) Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. J Cromatogr 423: 169
10. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymplioblastic leukaemia. Lancet 336: 229
11. Lewis AS, Murphy L, McCalla C, Fleary M, Purcell S (1984) Inhibition of mammalian xanthine oxidase by folate compounds and amethopterin. J Biol Chem 259: 12
12. Liliemark J, Pettersson B, Peterson C (1992) On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro. Leukemia Res 16: 275
13. McLeod HL, Relling MV, Liu Q, Pui C-H, Evans WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemia blasts from children with acute lymphoblastic leukemia. Blood 85: 1897
14. Nelson JA, Parks RE (1972) Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in Sarcoma 180 cells. Cancer Res 32: 2034
15. Sant ME, Lyons SD, Phillips L, Christopherson RI (1992) Antifolates induce inhibition of amido phosphoribosyl-transferase in leukemia cells. J Biol Chem 267: 11038
16. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM (1992) Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 2: 148
17. Walker RC, Woodson LC, Weinshilboum RM (1981) Rat thiopurine methyltransferase assay procedure, developmental changes and strain variation. Biochem Pharmacol 30: 115
18. Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32: 651
19. Weinshilboum RM, Raymond FA, Pazmiño PA (1978) Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85: 323
20. Woods RA, Henderson RM, Henderson JF (1978) Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cells. Eur J Cancer 14: 765
21. Woodson LC, Dunnette JH, Weinshilboum RM (1982) Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunolitration studies. J Pharmacol Exp Ther 222: 174